The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. MAIA Biotechnology Inc’s current trading price is -55.22% away from its 52-week high, while its distance from the 52-week low is 37.86%. The stock’s price range for this period has been between $1.40 and $4.31 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.79 million for the day, a number notably higher than the average daily volume of 0.2 million over the last three months.
MAIA Biotechnology Inc ‘s stock market performance has been somewhat erratic.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
MAIA Biotechnology Inc (MAIA) has experienced a quarterly rise of 12.21% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 58.49M and boasts a workforce of 13 employees.
Analyzing Trading Volume and Moving Average Trends
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MAIA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
MAIA Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a loss of -2.53%.However, over the last six months, we can see a stronger performance of -10.65%. Over the last 30 days, the price of MAIA has leaped by -6.31%. And in the last five days, it has surged by 6.63%.
